To assess the antiviral efficacy , safety and adherence in patients switched to an abacavir-containing nucleoside reverse transcriptase inhibitor ( NRTI ) regimen after long-term HIV-1 RNA suppression with a dual NRTI/protease inhibitor ( PI ) combination .
